The Prescription Pricing for the People bill requires the FTC to study pharmaceutical intermediaries, including vertical integration.

Mr. President, earlier this week, myself, Senator Cassidy, and Senator Cornyn, along with 35 of our Republican colleagues, introduced an effort to block President Biden's plan to transfer student loan debt onto the back of hard-working…

I believe the key way that we can solve high prescription drug prices is to have more transparency.

Prohibits deceptive, unfair pricing schemes, including spread pricing and arbitrary clawbacks of payments made to pharmacies.

The Pharmacy Benefit Manager (PBM) Transparency Act (S. 127) requires transparency reporting by PBMs to shine sunlight on prices and fees associated with prescription drugs.

Prohibits deceptive, unfair pricing schemes, including spread pricing and arbitrary clawbacks of payments made to pharmacies.

I believe the key way that we can solve high prescription drug prices is to have more transparency.

This bill puts sunshine on PBMs and saves taxpayers $740 million.

In the Grassley-Wyden 2-year investigation into insulin price-gouging, we found that that PBM scheme encourages drug makers to spike the drug list price.

The current drug price system is so opaque that it is easy to see why there are many questions about PBM motives and practices.

Something ought to get done this Congress, considering the fact that there is already a bill out of Judiciary, a bill out of Commerce.

The Pharmacy Benefit Manager (PBM) Transparency Act (S. 127) requires transparency reporting by PBMs to shine sunlight on prices and fees associated with prescription drugs.

There is not enough money in that program.

I think it is important for people to know who is actually receiving SNAP.

I think it is important for people to know who is actually receiving SNAP.

The current drug price system is so opaque that it is easy to see why there are many questions about PBM motives and practices.

In the Grassley-Wyden 2-year investigation into insulin price-gouging, we found that that PBM scheme encourages drug makers to spike the drug list price.

States know who the recipients are because they administer the SNAP Program, and they also know where the jobs are.